Skip to content
CNS Clinical Research

Iowa

CNS clinical trials in Iowa

28 CNS studies are recruiting participants at sites in 13 cities across Iowa as of November 16, 2026, according to ClinicalTrials.gov.

Call (888) 520-7418
  • No cost to ask
  • Taking part is voluntary
  • Studies are independently reviewed

Every Iowa city with a recruiting study

By research area: Depression (10), Migraine (7), Multiple Sclerosis (3), Parkinson's Disease (3), Epilepsy (2), ADHD (1), Bipolar Disorder (1), Schizophrenia (1).

Iowa City (20), West Des Moines (4), Ames (2), Sioux City (2), Waterloo (2), Ankeny (1), Bettendorf (1), Carroll (1), Cedar Rapids (1), Clive (1), Des Moines (1), Pella (1), Waukee (1).

The number after each city is how many studies have a recruiting site there. A study with sites in several cities is counted in each one.

Depression: recently updated in Iowa

Basic details from each study's public record (the 12 most recently updated of 28). Select a study to read the full record on ClinicalTrials.gov, including how to contact its team.

  1. Regulated Stimulation for Optimized Network Activity and Therapeutic Equilibrium

    • No phase
    • Ages 22 to 85
    • All sexes
    Sponsor
    Motif Neurotech, Inc.
    Recruiting in
    Iowa City
    Registry record
    NCT07594483 · updated
  2. E-Mindfulness Approaches for Living After Breast Cancer

    • Phase 3
    • Ages 18 to 50
    • All sexes
    Sponsor
    NRG Oncology
    Recruiting in
    Ankeny · Bettendorf · Carroll · and 6 more U.S. locations
    Registry record
    NCT06748222 · updated
  3. A Study to Evaluate the Maintenance Effect of Osavampator as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)

    • Phase 3
    • Ages 18 and older
    • All sexes
    Sponsor
    Neurocrine Biosciences
    Recruiting in
    Iowa City
    Registry record
    NCT07196501 · updated

Source: ClinicalTrials.gov. Data processed . See every depression study recruiting in Iowa on ClinicalTrials.gov.

Bipolar disorder: recently updated in Iowa

  1. A Study of Brenipatide in Adult Participants With Bipolar Disorder (RENEW-Bipolar-1)

    • Phase 2
    • Ages 18 to 75
    • All sexes
    Sponsor
    Eli Lilly and Company
    Recruiting in
    Waterloo
    Registry record
    NCT07286175 · updated

Source: ClinicalTrials.gov. Data processed . See every bipolar disorder study recruiting in Iowa on ClinicalTrials.gov.

Multiple sclerosis (MS): recently updated in Iowa

  1. Evaluation of an Online, On Demand Multimodal Wellness Program to Reduce Fatigue and Improve Quality of Life in Progressive Multiple Sclerosis.

    • No phase
    • Ages 45 to 70
    • All sexes
    Sponsor
    University of Iowa
    Recruiting in
    Iowa City
    Registry record
    NCT07831928 · updated
  2. Study to Evaluate Safety, Efficacy and Pharmacokinetics (PK) of a Modified Regimen of Ublituximab

    • Phase 3
    • Ages 18 to 65
    • All sexes
    Sponsor
    TG Therapeutics, Inc.
    Recruiting in
    Iowa City
    Registry record
    NCT05877963 · updated

Source: ClinicalTrials.gov. Data processed . See every multiple sclerosis study recruiting in Iowa on ClinicalTrials.gov.

Epilepsy: recently updated in Iowa

  1. Study of NRTX-1001 Neural Cell Therapy in Drug-Resistant Unilateral Mesial Temporal Lobe Epilepsy (EPIC (EPIlepsy Cell Therapy))

    • Phase 3
    • Ages 18 to 75
    • All sexes
    Sponsor
    Neurona Therapeutics
    Recruiting in
    Iowa City
    Registry record
    NCT05135091 · updated

Source: ClinicalTrials.gov. Data processed . See every epilepsy study recruiting in Iowa on ClinicalTrials.gov.

Migraine: recently updated in Iowa

  1. A Study to Assess the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine

    • Phase 3
    • Ages 18 to 75
    • All sexes
    Sponsor
    TriGemX Bio, Inc.
    Recruiting in
    Ames · Sioux City
    Registry record
    NCT07816367 · updated
  2. A Study to Evaluate the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine

    • Phase 3
    • Ages 18 to 75
    • All sexes
    Sponsor
    TriGemX Bio, Inc.
    Recruiting in
    West Des Moines
    Registry record
    NCT07645924 · updated
  3. A Long-Term Safety Study of Elismetrep (K-304) in the Acute Treatment of Migraine

    • Phase 3
    • Ages 18 and older
    • All sexes
    Sponsor
    TriGemX Bio, Inc.
    Recruiting in
    West Des Moines
    Registry record
    NCT07674654 · updated
  4. Randomized Study in Children and Adolescents With Migraine: Acute Treatment

    • Phase 3
    • Ages 6 to 17
    • All sexes
    Sponsor
    Pfizer
    Recruiting in
    Sioux City · West Des Moines
    Registry record
    NCT04649242 · updated
  5. Long-term Safety Study of Rimegepant in Pediatric Subjects for the Acute Treatment of Migraine

    • Phase 3
    • Ages 6 to 17
    • All sexes
    Sponsor
    Pfizer
    Recruiting in
    West Des Moines
    Registry record
    NCT04743141 · updated

Source: ClinicalTrials.gov. Data processed . See every migraine study recruiting in Iowa on ClinicalTrials.gov.

Ask about studies in Iowa

Tell us what you are looking for and a coordinator will contact you to talk through your options. Asking does not commit you to anything.

How should we reach you?
Add a message or the best time to reach you (optional)

Please do not include detailed medical information.

Before you contact a study

About these listings

These listings come from ClinicalTrials.gov, the study registry run by the U.S. National Library of Medicine. The data were processed on November 16, 2026. We show part of each public record (its title, phase, sponsor, basic eligibility and sites in this area) exactly as registered, and we group studies by place. Nothing in a record is reworded.

CNS Clinical Research does not run these studies and is not affiliated with their sponsors. A listing is not a recommendation, and only a study's own team can tell you whether you may be eligible. Follow the link on any study to read its full record and contact that team directly, or ask us and a coordinator will help you understand your options. How we source and check what we publish.

Sources and further reading

Ask about a study

A coordinator will contact you. Asking does not commit you to anything.

Call (888) 520-7418

or send a short form

How should we reach you?

Call